BioMarin completes acquisition of Alesta Therapeutics B.V.

BIOMARIN PHARMACEUTICAL INC

Completed share purchase of Alesta Therapeutics on Aug 31, 2026; Alesta now wholly owned subsidiary.
Acquisition follows Share Purchase Agreement first filed Aug 18, 2026; no new deal terms disclosed.
BioMarin (BMRN) expands portfolio via Alesta; purchase price not stated in this 8-K.

item 8.01

BIOMARIN PHARMACEUTICAL INC filing history →

Source: SEC EDGAR

accession 0001193125-26-377696

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.